title: A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group Study.
authors.affiliation: Department of Medicine, Queen Elizabeth Hospital, Edgbaston, Birmingham, U.K.
authors.forename: G
authors.initials: G
authors.lastname: Blackledge
authors.forename: J
authors.initials: J
authors.lastname: Verweij
authors.forename: R
authors.initials: R
authors.lastname: Fuchs
authors.forename: H J
authors.initials: HJ
authors.lastname: Keizer
authors.forename: R
authors.initials: R
authors.lastname: Somers
authors.forename: E
authors.initials: E
authors.lastname: Rankin
authors.forename: P
authors.initials: P
authors.lastname: Kerbrat
authors.forename: A
authors.initials: A
authors.lastname: van Oosterom
authors.forename: R
authors.initials: R
authors.lastname: Sylvester
authors.forename: D
authors.initials: D
authors.lastname: Thomas
mesh_terms: D000328:Adult; D000368:Aged; D001386:Azides / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D011739:Pyrimethamine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012509:Sarcoma / Q000188:drug therapy*; D012983:Soft Tissue Neoplasms / Q000188:drug therapy*
chemical_list: D001386:Azides; C055910:3-azidopyrimethamine; D011739:Pyrimethamine